Whitebox Advisors’s eFFECTOR Therapeutics, Inc. Warrant EFTRW Stock Holding History

Whitebox Advisors’s Portfolio EFTRW Stock Details EFTRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-298,145	Closed	-$262K	–	982
2021 Q4	$262K	Buy	298,145 +79,698	+36%	+$100K	0.01%	535
2021 Q3	$350K	Buy	218,447 +185,114	+555%	+$225K	0.01%	430
2021 Q2	$33K	Buy	+33,333	New	+$26.9K	﹤0.01%	461

Whitebox Advisors's EFTRW Position: Q3 2024 in Review

Whitebox Advisors sold out of eFFECTOR Therapeutics, Inc. Warrant (EFTRW) in Q3 2024, closing a stake of 298,145 shares — an estimated $358 sold.

Whitebox Advisors first reported a position in EFTRW in Q1 2021 and held it in 11 quarters. The position peaked at $128K in Q1 2022. 1 fund tracked by Wall St. Rank holds EFTRW as of Q3 2024.

Whitebox Advisors reported no remaining eFFECTOR Therapeutics, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
Whitebox Advisors sold 298,145 eFFECTOR Therapeutics, Inc. Warrant shares in Q3 2024, an estimated $358.
Whitebox Advisors first reported a position in eFFECTOR Therapeutics, Inc. Warrant in Q1 2021 and held it in 11 quarters.
Whitebox Advisors's eFFECTOR Therapeutics, Inc. Warrant position peaked at $128K in Q1 2022.
1 fund tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Warrant as of Q3 2024.

Based on Whitebox Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.